Ultragenyx CEO talks the company’s path to profitability in developing drugs for rare diseases
Dr. Emil Kakkis, Ultragenyx founder & CEO, joins ‘Closing Bell Overtime’ to talk drug trials and development, its path to profitability and more.
Similar Posts
Lightning Round: IBM is inexpensive and ‘a pretty good stock’, says Jim Cramer
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email ‘Mad Money’ host Jim Cramer weighs in on viewer stock picks including: MBIA, Whirlpool, Carnival Cruise Line, Modine Manufacturing, DraftKings and IBM. 04:49 Thu, Dec 14 20237:52 PM EST
Investors should be looking for growth factors without sacrificing: Charles Schwab’s Liz Ann Sonders
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Liz Ann Sonders, Charles Schwab chief investment strategist, joins ‘Closing Bell’ to discuss the CPI report, jobs data impact on the markets, and more.
Can I afford it? Hall of fame
Suze Orman remembers some the most memorable moments from her “Can I Afford It” segment.
Shari Redstone launches formal auction of National Amusements: Report
CNBC’s Andrew Ross Sorkin reports on the latest news.
Skylar Capital’s Bill Perkins calls Chesapeake & Southwestern possible merger ‘brilliant’
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Bill Perkins, Skylar Capital founder, and CNBC’s Pippa Stevens join ‘Power Lunch’ to discuss a possible merger between Chesapeake and Southwestern and natural gas outlook. 03:42 Wed, Jan 10 20242:59 PM EST
Taiwan: the world’s new whiskey capital?
The results are in, and Taiwan’s Kavalan distillery has the best single-malt whiskey in 2015.
